Kaliumjodid Serb

Potassium Iodide, the active ingredient in Kaliumjodid Serb, is a thyroid blocking agent presented as an oral preparation for oral use. It is employed to protect the thyroid gland by saturating it with stable iodine, thereby reducing the uptake of radioactive iodine isotopes during radiation emergencies or medical procedures involving iodine‑131.

GNH USA supplies Kaliumjodid Serb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Kaliumjodid Serb, a thyroid blocking agent, is used to mitigate iodine uptake in the thyroid gland during radiation exposure.

- Radiation emergency prophylaxis: provides thyroid protection by saturating the gland with stable iodine, reducing radioactive iodine uptake. - Thyroid protection during nuclear incidents: prevents accumulation of harmful iodine isotopes in the thyroid, lowering risk of radiation‑induced thyroid disease. - Prevention of radioactive iodine uptake in patients receiving I‑131 therapy: limits thyroid exposure to therapeutic radioiodine, helping to control dose to non‑target tissues.

Kaliumjodid Serb may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset after ingestion. - Metallic taste: transient alteration of taste perception. - Headache: occasional mild headache following dosing.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis in sensitive individuals. - Iodide‑induced thyroid dysfunction: hyperthyroidism or severe hypothyroidism. - Thyroid storm (rare): acute, life‑threatening exacerbation of hyperthyroidism. - Severe vomiting: can lead to dehydration and electrolyte imbalance.

Before using Kaliumjodid Serb, certain precautions should be observed to ensure safety. - Assess thyroid function: evaluate baseline thyroid status prior to administration. - Monitor for iodine sensitivity: watch for signs of allergic reaction during treatment. - Avoid in known iodine allergy: contraindicated in patients with documented hypersensitivity to iodide. - Use with caution in pregnancy or breastfeeding: weigh potential benefits against risks. - Adjust in renal impairment: consider dose modification for patients with reduced kidney function. - Store at room temperature: keep in the original pack, protect from moisture.

Potassium iodide can interact with several medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Lithium: concurrent use may increase risk of thyroid dysfunction. - Antithyroid drugs (e.g., propylthiouracil, methimazole): may reduce the effectiveness of potassium iodide. - Amiodarone: excess iodine load can exacerbate thyroid abnormalities.

Moderate Interactions (Monitor Closely): - ACE inhibitors: potential for altered potassium balance. - Potassium‑sparing diuretics: may increase systemic iodide levels. - Radioactive iodine therapy: potassium iodide can interfere with intended therapeutic uptake. - Thyroid hormone replacement: dosage adjustments may be required.